يعرض 1 - 20 نتائج من 115,063 نتيجة بحث عن '"Histamine"', وقت الاستعلام: 0.61s تنقيح النتائج
  1. 1
    Academic Journal

    المؤلفون: Özel, H. Fehmi1 (AUTHOR) fehmiozel@gmail.com, Özbek, Mustafa2 (AUTHOR), Özden, Merve Temel3 (AUTHOR), Vatansever, H. Seda4,5 (AUTHOR)

    المصدر: Pflügers Archiv: European Journal of Physiology. Feb2025, Vol. 477 Issue 2, p291-301. 11p.

  2. 2
    Academic Journal

    المؤلفون: Peng, Xinli1 (AUTHOR), Wang, Siqi1 (AUTHOR), Su, Kaiyue1 (AUTHOR), Sun, Yufeng1 (AUTHOR), Xu, Zhixiang1 (AUTHOR) zhixiangxu@sina.com

    المصدر: Journal of the Science of Food & Agriculture. 1/30/2025, Vol. 105 Issue 2, p791-797. 7p.

    مصطلحات موضوعية: *HYPOTENSION, *HISTAMINE, *SOY sauce, *LIQUID chromatography, *CHEMICAL industry

  3. 3
    Academic Journal

    المؤلفون: Zheng, Long1 (AUTHOR) zhenglong@sioc.ac.cn, Li, Ying‐Chao1 (AUTHOR), Wu, Yichen1 (AUTHOR), Wang, Peng1,2,3 (AUTHOR) pengwang@sioc.ac.cn

    المصدر: Advanced Science. 12/4/2024, Vol. 11 Issue 45, p1-9. 9p.

  4. 4
    Academic Journal

    المؤلفون: Gregnani, Marcos Fernandes1 (AUTHOR), Martins, Leonardo2 (AUTHOR) leonardo.martin@uantwerpen.be, Fogel, Wieslawa Agnieszka3 (AUTHOR) leonardo.martin@uantwerpen.be

    المصدر: Receptors. Dec2024, Vol. 3 Issue 4, p513-537. 25p.

  5. 5
    Academic Journal
  6. 6
    Academic Journal

    المؤلفون: Yegin, Bengi1 (AUTHOR) bengiyegin@gmail.com, Donmez, Dilek Burukoglu2 (AUTHOR), Oz, Semih3 (AUTHOR), Aydin, Sule4 (AUTHOR)

    المصدر: International Journal of Neuroscience. Dec2024, Vol. 134 Issue 12, p1569-1581. 13p.

  7. 7
    Dissertation/ Thesis

    المؤلفون: Sánchez Pérez, Sònia

    المساهمون: University/Department: Universitat de Barcelona. Departament de Nutrició, Ciències de l'Alimentació i Gastronomia

    Thesis Advisors: Vidal Carou, Ma. Carmen, Latorre Moratalla, Mariluz, Veciana Nogués, María Teresa

    المصدر: TDX (Tesis Doctorals en Xarxa)

    وصف الملف: application/pdf

  8. 8
    Academic Journal

    المؤلفون: Jończyk, Jakub1,2 (AUTHOR) jakub.jonczyk@uj.edu.pl, Przybylska, Klaudia1 (AUTHOR) justyna.godyn@uj.edu.pl, Staszewski, Marek3 (AUTHOR) marek.staszewski@umed.lodz.pl, Godyń, Justyna1 (AUTHOR), Werner, Tobias4 (AUTHOR) t.werner@hhu.de, Stefaniak-Napieralska, Monika3 (AUTHOR) monika.stefaniak@umed.lodz.pl, Stark, Holger4 (AUTHOR) stark@hhu.de, Walczyński, Krzysztof3 (AUTHOR) krzysztof.walczynski@umed.lodz.pl, Bajda, Marek1 (AUTHOR) marek.bajda@uj.edu.pl

    المصدر: Molecules. Nov2024, Vol. 29 Issue 22, p5271. 14p.

  9. 9
    Academic Journal

    المؤلفون: Arrang, J.‐M.1 (AUTHOR), Armand, V.1 (AUTHOR) vincent.armand@parisdescartes.fr

    المصدر: Pharmacology Research & Perspectives. Oct2024, Vol. 12 Issue 5, p1-9. 9p.

  10. 10
    Report

    المصدر: A Phase IIIb Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis

  11. 11
    Report

    المساهمون: Anna Puigdellívol-Sánchez, M.D., Ph.D.

    المصدر: Evaluation of Influenza Vaccination and Treatment With ACEI and ARB in the Evolution of SARS-CoV2 Infection
    Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020 May;92(5):479-490. doi: 10.1002/jmv.25707. Epub 2020 Mar 3.
    Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics. Drug Dev Res. 2020 Aug;81(5):537-540. doi: 10.1002/ddr.21656. Epub 2020 Mar 4.
    Moran Blanco JI, Alvarenga Bonilla JA, Homma S, Suzuki K, Fremont-Smith P, Villar Gomez de Las Heras K. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients. Pulm Pharmacol Ther. 2021 Apr;67:101989. doi: 10.1016/j.pupt.2021.101989. Epub 2021 Jan 16.
    Cortes-Borra A, Aranda-Abreu GE. Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2. Pharmacol Rep. 2021 Jun;73(3):962-965. doi: 10.1007/s43440-021-00231-5. Epub 2021 Feb 18.
    Puigdellivol-Sanchez A, Juanes-Gonzalez M, Calderon-Valdiviezo A, Valls-Foix R, Gonzalez-Salvador M, Lozano-Paz C, Vidal-Alaball J. COVID-19 in Relation to Polypharmacy and Immunization (2020-2024). Viruses. 2024 Sep 27;16(10):1533. doi: 10.3390/v16101533.
    Puigdellivol-Sanchez A, Juanes-Gonzalez M, Calderon-Valdiviezo A, Losa-Puig H, Valls-Foix R, Gonzalez-Salvador M, Lozano-Paz C, Vidal-Alaball J. COVID-19 in Relation to Chronic Antihistamine Prescription. Microorganisms. 2024 Dec 13;12(12):2589. doi: 10.3390/microorganisms12122589.

  12. 12
    Report

    المؤلفون: Institut Català de la Salut

    المساهمون: Anna Puigdellívol-Sánchez, Principal Investigator

    المصدر: Evaluation of Treatments With Antihistamines and Amantadine in the Evolution of the SARS-CoV-2 Infection
    Moran Blanco JI, Alvarenga Bonilla JA, Homma S, Suzuki K, Fremont-Smith P, Villar Gomez de Las Heras K. Antihistamines and azithromycin as a treatment for COVID-19 on primary health care - A retrospective observational study in elderly patients. Pulm Pharmacol Ther. 2021 Apr;67:101989. doi: 10.1016/j.pupt.2021.101989. Epub 2021 Jan 16.
    Cortes-Borra A, Aranda-Abreu GE. Amantadine in the prevention of clinical symptoms caused by SARS-CoV-2. Pharmacol Rep. 2021 Jun;73(3):962-965. doi: 10.1007/s43440-021-00231-5. Epub 2021 Feb 18.
    Puigdellivol-Sanchez A, Juanes-Gonzalez M, Calderon-Valdiviezo A, Losa-Puig H, Valls-Foix R, Gonzalez-Salvador M, Lozano-Paz C, Vidal-Alaball J. COVID-19 in Relation to Chronic Antihistamine Prescription. Microorganisms. 2024 Dec 13;12(12):2589. doi: 10.3390/microorganisms12122589.
    Puigdellivol-Sanchez A, Juanes-Gonzalez M, Calderon-Valdiviezo A, Valls-Foix R, Gonzalez-Salvador M, Lozano-Paz C, Vidal-Alaball J. COVID-19 in Relation to Polypharmacy and Immunization (2020-2024). Viruses. 2024 Sep 27;16(10):1533. doi: 10.3390/v16101533.

  13. 13
    Report

    المصدر: KEYMAKER-U01 Substudy 01E: A Phase 2 Umbrella Study With Rolling Arms of Investigational Agents With or Without Chemotherapy in Combination With Pembrolizumab in Treatment of Participants With Newly Diagnosed Resectable Stages II-IIIB (N2) Non-small Cell Lung Cancer (NSCLC)

  14. 14
    Report

    المصدر: A Phase 1 Study of H3B-6545 in Japanese Women With Estrogen Receptor-positive, HER2 Negative Breast Cancer
    Furman C, Puyang X, Zhang Z, Wu ZJ, Banka D, Aithal KB, Albacker LA, Hao MH, Irwin S, Kim A, Montesion M, Moriarty AD, Murugesan K, Nguyen TV, Rimkunas V, Sahmoud T, Wick MJ, Yao S, Zhang X, Zeng H, Vaillancourt FH, Bolduc DM, Larsen N, Zheng GZ, Prajapati S, Zhu P, Korpal M. Covalent ERalpha Antagonist H3B-6545 Demonstrates Encouraging Preclinical Activity in Therapy-Resistant Breast Cancer. Mol Cancer Ther. 2022 Jun 1;21(6):890-902. doi: 10.1158/1535-7163.MCT-21-0378.

  15. 15
    Report

    المصدر: A Randomized, Open-label, Phase 3 Study of MK-2870 vs. Platinum Doublets in Participants With EGFR-mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors

  16. 16
    Report

    المصدر: A Phase 1/2 Open-Label, Umbrella Platform Design Study of Investigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Esophageal Cancer Previously Exposed to PD-1/PD-L1 Treatment (KEYMAKER-U06): Substudy 06B

  17. 17
    Report

    المصدر: A Phase IIIB Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

  18. 18
    Report

    المؤلفون: Regeneron Pharmaceuticals

    المصدر: Master Protocol of Three Randomized, Double-blind, Placebo Controlled, Multi-center, Parallel-group Studies of Dupilumab in Patients With Chronic Spontaneous Urticaria (CSU) Who Remain Symptomatic Despite the Use of H1 Antihistamine Treatment in Patients naïve to Omalizumab and in Patients Who Are Intolerant or Incomplete Responders to Omalizumab

  19. 19
    Academic Journal
  20. 20
    Academic Journal

    المؤلفون: Li, Quxiang1 (AUTHOR) liquxiang@163.com, Ren, Lili1 (AUTHOR) renlili@njtech.edu.cn, Wang, Dongli2 (AUTHOR) wangdongli@nhwa-group.com, Luo, Junyong1 (AUTHOR) junyongluo@163.com, Xu, Changda2 (AUTHOR) xuchangda@nhwa-group.com, Feng, Jian2 (AUTHOR) fengjian@nhwa-group.com, Qiu, Yufan3 (AUTHOR) yufan.qiu@pharmaron-bj.com, Xu, Xiangqing2 (AUTHOR) xuxiangqing@nhwa-group.com, Chen, Guoguang1 (AUTHOR) xuxiangqing@nhwa-group.com

    المصدر: Molecules. Nov2024, Vol. 29 Issue 22, p5240. 19p.